Fungi,
particularly filamentous fungi and macrofungi, have a very
powerful ability to produce secondary metabolites and can serve as
excellent chassis cells for the production of enzymes or natural products
of great value in synthetic biology. Thus, it is imperative to establish
simple, reliable, and efficient techniques for their genetic modification.
However, the heterokaryosis of some fungi and the dominance of nonhomologous
end-joining (NHEJ) repair mechanisms in vivo have
been greatly affecting the efficiency of fungal gene editing. In recent
years, the CRISPR/Cas9 system has been applied as a widely used gene
editing technology in life science research and has also played an
important role in the genetic modification of filamentous and macrofungi.
The various functional components (cas9, sgRNA, promoter, and screening
marker) of the CRISPR/Cas9 system and its development, as well as
the difficulties and potential of the CRISPR/Cas9 system in filamentous
fungus and macrofungi, are the main topics of this paper.